新里程收盘下跌2.28%，滚动市盈率64.65倍，总市值72.49亿元

Group 1 - The core viewpoint of the article highlights the financial performance and market position of New Mile Health Technology Group Co., Ltd, indicating a decline in revenue and net profit in the latest quarterly report [1] - As of August 14, the closing price of New Mile was 2.14 yuan, down 2.28%, with a rolling PE ratio of 64.65 times and a total market value of 7.249 billion yuan [1] - The company operates in the medical services and pharmaceutical industry, focusing on drug production for over 20 years, with its main product being the "Duyiwei" brand of traditional Chinese medicine [1] Group 2 - The latest quarterly report for Q1 2025 shows that the company achieved operating revenue of 796 million yuan, a year-on-year decrease of 16.49%, and a net profit of 25.6519 million yuan, down 9.35% year-on-year, with a sales gross margin of 27.96% [1] - In terms of industry comparison, the average PE ratio for the medical services industry is 49.00 times, with a median of 62.63 times, placing New Mile at the 31st position in the industry ranking [2] - The company has a significant brand presence, with "Duyiwei" being recognized as a famous Chinese trademark and included in the National Medical Insurance Directory [1]